Genky DrugStores Co., Ltd.
9267.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | ¥200,786,000 | ¥184,860,000 | ¥169,059,000 | ¥154,639,641 |
| % Growth | 8.6% | 9.3% | 9.3% | – |
| Cost of Goods Sold | ¥159,896,000 | ¥147,239,000 | ¥134,505,000 | ¥123,685,308 |
| Gross Profit | ¥40,890,000 | ¥37,621,000 | ¥34,554,000 | ¥30,954,333 |
| % Margin | 20.4% | 20.4% | 20.4% | 20% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥31,231,000 | ¥23,518,000 | ¥23,194,000 | ¥21,000,000 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥5,088,000 | ¥4,650,000 | ¥4,279,321 |
| Operating Expenses | ¥31,231,000 | ¥28,606,000 | ¥27,844,000 | ¥25,279,321 |
| Operating Income | ¥9,659,000 | ¥9,016,000 | ¥6,709,000 | ¥5,675,011 |
| % Margin | 4.8% | 4.9% | 4% | 3.7% |
| Other Income/Exp. Net | ¥243,000 | -¥213,000 | -¥6,000 | ¥408,770 |
| Pre-Tax Income | ¥9,902,000 | ¥8,803,000 | ¥6,704,000 | ¥6,083,770 |
| Tax Expense | ¥2,836,000 | ¥2,478,000 | ¥1,939,000 | ¥1,663,102 |
| Net Income | ¥7,066,000 | ¥6,324,000 | ¥4,764,000 | ¥4,420,000 |
| % Margin | 3.5% | 3.4% | 2.8% | 2.9% |
| EPS | 232.49 | 207.94 | 156.89 | 145.59 |
| % Growth | 11.8% | 32.5% | 7.8% | – |
| EPS Diluted | 232.02 | 207.91 | 156.79 | 145.44 |
| Weighted Avg Shares Out | 30,393 | 30,377 | 30,384 | 30,391 |
| Weighted Avg Shares Out Dil | 30,455 | 30,416 | 30,390 | 30,396 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥10,000 | ¥7,000 | ¥8,000 | ¥9,012 |
| Interest Expense | ¥216,000 | ¥103,000 | ¥70,000 | ¥59,090 |
| Depreciation & Amortization | ¥6,292,000 | ¥5,566,000 | ¥4,955,000 | ¥4,592,078 |
| EBITDA | ¥16,410,000 | ¥14,474,000 | ¥11,729,000 | ¥10,734,939 |
| % Margin | 8.2% | 7.8% | 6.9% | 6.9% |